Skip to main content

Advertisement

Log in

Observed transaminitis with a unique bacteriophage therapy protocol to treat recalcitrant Staphylococcal biofilm infections

  • Correspondence
  • Published:
Infection Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Doub JB. Bacteriophage therapy for clinical biofilm infections: parameters that influence treatment protocols and current treatment approaches. Antibiotics (Basel). 2020;9:799.

    Article  CAS  Google Scholar 

  2. Dąbrowska K. Phage therapy: What factors shape phage pharmacokinetics and bioavailability? systematic and critical review. Med Res Rev. 2019;39:2000–25.

    Article  Google Scholar 

  3. Aslam S, Lampley E, Wooten D, Karris M, Benson C, Strathdee S, Schooley R. Lessons learned from the first 10 consecutive cases of intravenous bacteriophage therapy to treat multidrug-resistant bacterial infections at a single center in the United States. Open Forum Infect Dis. 2020;7:389.

    Article  Google Scholar 

  4. Onsea J, Soentjens P, Djebara S, Merabishvili M, Depypere M, Spriet I, De Munter P, Debaveye Y, Nijs S, Vanderschot P, Wagemans J, Pirnay JP, Lavigne R, Metsemakers WJ. Bacteriophage application for difficult-to-treat musculoskeletal infections: development of a standardized multidisciplinary treatment protocol. Viruses. 2019;11:891.

    Article  CAS  Google Scholar 

  5. Chang RYK, Wallin M, Lin Y, Leung SSY, Wang H, Morales S, Chan HK. Phage therapy for respiratory infections. Adv Drug Deliv Rev. 2018;133:76–86.

    Article  CAS  Google Scholar 

  6. Ferry T, Kolenda C, Batailler C, Gustave CA, Lustig S, Malatray M, et al. Phage therapy as adjuvant to conservative surgery and antibiotics to salvage patients with relapsing S. aureus prosthetic knee infection. Front Med. 2020;7:570572.

    Article  Google Scholar 

  7. Doub JB, Ng VY, Johnson AJ, Slomka M, Fackler J, Horne B, Brownstein MJ, Henry M, Malagon F, Biswas B. Salvage bacteriophage therapy for a chronic MRSA prosthetic joint infection. Antibiotics (Basel). 2020;9:241.

    Article  Google Scholar 

  8. Hansen MF, Svenningsen SL, Røder HL, Middelboe M, Burmølle M. Big impact of the tiny: bacteriophage-bacteria interactions in biofilms. Trends Microbiol. 2019;27:739–52.

    Article  CAS  Google Scholar 

  9. Roy ME, Peppers MP, Whiteside LA, Lazear RM. Vancomycin concentration in synovial fluid: direct injection into the knee vs. intravenous infusion. J Arthroplasty. 2014;29:564–8.

    Article  Google Scholar 

Download references

Funding

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to James B. Doub.

Ethics declarations

Conflict of interest

None to declare.

Ethical approval

All patients gave informed consent to be administered bacteriophage therapy for their recalcitrant infections and to publish their cases and/or data. All patients included had individual IND’s granted by the FDA through the expanded access pathway. These were individually reviewed and approved by the University of Maryland IRB.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Doub, J.B., Wilson, E. Observed transaminitis with a unique bacteriophage therapy protocol to treat recalcitrant Staphylococcal biofilm infections. Infection 50, 281–283 (2022). https://doi.org/10.1007/s15010-021-01675-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15010-021-01675-w

Navigation